257 related articles for article (PubMed ID: 12915482)
21. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
Jiang H; Ren Y; Zhao J; Feng J
Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
[TBL] [Abstract][Full Text] [Related]
22. Parkin attenuates manganese-induced dopaminergic cell death.
Higashi Y; Asanuma M; Miyazaki I; Hattori N; Mizuno Y; Ogawa N
J Neurochem; 2004 Jun; 89(6):1490-7. PubMed ID: 15189352
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals.
Hattori N; Kitada T; Matsumine H; Asakawa S; Yamamura Y; Yoshino H; Kobayashi T; Yokochi M; Wang M; Yoritaka A; Kondo T; Kuzuhara S; Nakamura S; Shimizu N; Mizuno Y
Ann Neurol; 1998 Dec; 44(6):935-41. PubMed ID: 9851438
[TBL] [Abstract][Full Text] [Related]
24. Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice.
Serrano A; Menéndez J; Casarejos MJ; Solano RM; Gallego E; Sánchez M; Mena MA; García de Yebenes J
Neuropharmacology; 2005 Aug; 49(2):208-19. PubMed ID: 15993444
[TBL] [Abstract][Full Text] [Related]
25. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
26. Parkin-deficient mice are not a robust model of parkinsonism.
Perez FA; Palmiter RD
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2174-9. PubMed ID: 15684050
[TBL] [Abstract][Full Text] [Related]
27. Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation.
Kitao Y; Imai Y; Ozawa K; Kataoka A; Ikeda T; Soda M; Nakimawa K; Kiyama H; Stern DM; Hori O; Wakamatsu K; Ito S; Itohara S; Takahashi R; Ogawa S
Hum Mol Genet; 2007 Jan; 16(1):50-60. PubMed ID: 17116640
[TBL] [Abstract][Full Text] [Related]
28. Parkin is protective against proteotoxic stress in a transgenic zebrafish model.
Fett ME; Pilsl A; Paquet D; van Bebber F; Haass C; Tatzelt J; Schmid B; Winklhofer KF
PLoS One; 2010 Jul; 5(7):e11783. PubMed ID: 20689587
[TBL] [Abstract][Full Text] [Related]
29. Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.
Hyun DH; Lee M; Halliwell B; Jenner P
J Neurosci Res; 2005 Oct; 82(2):232-44. PubMed ID: 16130151
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic mutations inactivate parkin by distinct mechanisms.
Henn IH; Gostner JM; Lackner P; Tatzelt J; Winklhofer KF
J Neurochem; 2005 Jan; 92(1):114-22. PubMed ID: 15606901
[TBL] [Abstract][Full Text] [Related]
31. A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.
Omura T; Kaneko M; Okuma Y; Orba Y; Nagashima K; Takahashi R; Fujitani N; Matsumura S; Hata A; Kubota K; Murahashi K; Uehara T; Nomura Y
J Neurochem; 2006 Dec; 99(6):1456-69. PubMed ID: 17059562
[TBL] [Abstract][Full Text] [Related]
32. Parkin potentiates ATP-induced currents due to activation of P2X receptors in PC12 cells.
Sato A; Arimura Y; Manago Y; Nishikawa K; Aoki K; Wada E; Suzuki Y; Osaka H; Setsuie R; Sakurai M; Amano T; Aoki S; Wada K; Noda M
J Cell Physiol; 2006 Oct; 209(1):172-82. PubMed ID: 16826604
[TBL] [Abstract][Full Text] [Related]
33. [Animal models for familial Parkinson's disease].
Takahashi R
Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
[TBL] [Abstract][Full Text] [Related]
34. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
35. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
[TBL] [Abstract][Full Text] [Related]
36. Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways.
Hasegawa T; Treis A; Patenge N; Fiesel FC; Springer W; Kahle PJ
J Neurochem; 2008 Jun; 105(5):1700-15. PubMed ID: 18248610
[TBL] [Abstract][Full Text] [Related]
37. Pael receptor is involved in dopamine metabolism in the nigrostriatal system.
Imai Y; Inoue H; Kataoka A; Hua-Qin W; Masuda M; Ikeda T; Tsukita K; Soda M; Kodama T; Fuwa T; Honda Y; Kaneko S; Matsumoto S; Wakamatsu K; Ito S; Miura M; Aosaki T; Itohara S; Takahashi R
Neurosci Res; 2007 Dec; 59(4):413-25. PubMed ID: 17889953
[TBL] [Abstract][Full Text] [Related]
38. Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau.
Navarro P; Guerrero R; Gallego E; Avila J; Luquin R; Garcia Ruiz PJ; Sanchez MP
J Neurol Sci; 2008 Dec; 275(1-2):139-44. PubMed ID: 18817929
[TBL] [Abstract][Full Text] [Related]
39. Parkin expression profile in dopamine d3 receptor knock-out mice brains.
D'Agata V; Tiralongo A; Castorina A; Leggio GM; Micale V; Carnazza ML; Drago F
Neurochem Res; 2009 Feb; 34(2):327-32. PubMed ID: 18612813
[TBL] [Abstract][Full Text] [Related]
40. Differential expression and tissue distribution of parkin isoforms during mouse development.
Huynh DP; Dy M; Nguyen D; Kiehl TR; Pulst SM
Brain Res Dev Brain Res; 2001 Oct; 130(2):173-81. PubMed ID: 11675120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
